Evidity Health Capital
Overview
Evidity Health Capital is a late-stage venture capital and growth equity firm that specializes in medical devices, in vitro diagnostics, and disruptive digital health.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Endoluminal Solutions Inc. | May 2019 | Series I | Co-investor |
| Sonde Health | Apr 2019 | Series A | Co-investor |
| Augmedics | Jun 2023 | Series D | Co-investor |
| PreludeDx | Mar 2022 | VC Round | Lead |
| Dilon Technologies Inc. | Aug 2017 | Early Funding | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Evidity Health Capital based?
Evidity Health Capital is headquartered in Miami, Florida, United States.
When was Evidity Health Capital founded?
Evidity Health Capital was founded in 2014.
How many portfolio companies does Evidity Health Capital have?
Evidity Health Capital has 8 portfolio companies in Caplight's dataset.
What are some companies in Evidity Health Capital's portfolio?
Portfolio companies visible on Caplight include Endoluminal Solutions Inc., Sonde Health, Augmedics, PreludeDx, Dilon Technologies Inc..
What was Evidity Health Capital's most recent investment shown here?
Evidity Health Capital's most recent investment in this portfolio sample was in Augmedics in 2023.
What sectors does Evidity Health Capital focus on?
Evidity Health Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Evidity Health Capital focus on?
Evidity Health Capital typically invests at the Late stage.